EKF Diagnostics (LON:EKF) Shares Pass Above 200-Day Moving Average of $28.99

EKF Diagnostics Holdings plc (LON:EKFGet Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 28.99 ($0.37) and traded as high as GBX 32.83 ($0.42). EKF Diagnostics shares last traded at GBX 32.60 ($0.42), with a volume of 378,066 shares traded.

EKF Diagnostics Stock Performance

The firm has a market capitalization of £147.92 million, a price-to-earnings ratio of 3,260.00 and a beta of 0.56. The firm’s 50-day moving average price is GBX 28.94 and its two-hundred day moving average price is GBX 28.99. The company has a debt-to-equity ratio of 6.01, a quick ratio of 1.77 and a current ratio of 2.69.

Insiders Place Their Bets

In related news, insider Christopher H. B. Mills acquired 100,000 shares of the stock in a transaction dated Friday, March 22nd. The shares were bought at an average cost of GBX 26 ($0.33) per share, for a total transaction of £26,000 ($33,205.62). Corporate insiders own 5.11% of the company’s stock.

About EKF Diagnostics

(Get Free Report)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

Further Reading

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.